# ClinicalTrials.gov record NCT04589819

> PeptideScanner retained ClinicalTrials.gov record NCT04589819 at 2026-07-30T19:16:22.171Z. Its registry update date was 2023-02-13, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct04589819-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-02-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04589819-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04589819-teriparatide-v1.json
- Content SHA-256: `56448e440a2a55f2c0949f35f00019b314d2a3b1d7acafd38b9bb34b6a44b503`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04589819 ([`ctg-observation-nct04589819-2023-02-13-3caae8baa175`](#source-ctg-observation-nct04589819-2023-02-13-3caae8baa175))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04589819 at 2026-07-30T19:16:22.171Z. Its registry update date was 2023-02-13, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct04589819-2023-02-13-3caae8baa175`](#source-ctg-observation-nct04589819-2023-02-13-3caae8baa175))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04589819 at 2026-07-30T19:16:22.171Z. Its registry update date was 2023-02-13, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct04589819-2023-02-13-3caae8baa175`](#source-ctg-observation-nct04589819-2023-02-13-3caae8baa175))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04589819-2023-02-13-3caae8baa175`](#source-ctg-observation-nct04589819-2023-02-13-3caae8baa175))

## Sources

<a id="source-ctg-observation-nct04589819-2023-02-13-3caae8baa175"></a>
- **ClinicalTrials.gov record NCT04589819 · retained source version 2023-02-13:3caae8baa17551c2312527a2c2e939f36af0399bcdd6e43e0412bc2144d6922b** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04589819) (`ctg-observation-nct04589819-2023-02-13-3caae8baa175`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04589819." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04589819-teriparatide-v1.json SHA-256: 56448e440a2a55f2c0949f35f00019b314d2a3b1d7acafd38b9bb34b6a44b503.